GX Acquisition Corp.
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $287.50M |
|---|---|
| IPO Date | May 21, 2019 |
| CEO | Jay R. Bloom; Dean C. Kehler |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24+2 |
| IPO Sector |
General
Not specified |
| IPO Geography | Global |
| Target Company | Celularity |
| Deal Announced | Jan 8, 2021 |
| Deal Size, $M | $1,293.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Jul 14, 2021 |
| Amendment Vote | TBD |
| Closing Date | Jul 16, 2021 |
Formerly GXGX
CELU
CELUW
| Price | $2.94 $0.29 |
|---|---|
| Last closing price | $2.92 |
| H/L, today | $2.77 / $3.06 |
| H/L, 52-week | $0.19 / $2.45 |
| Volume, today | 121,055 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on GX Acquisition Corp.:
- Structure and cap table
- 7 directors & officers
- 28 filings and events
- 1 underwriters
- 7 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jay R. Bloom | 63 | Co-Chairman & CEO |
| Dean C. Kehler | 62 | Co-Chairman and CEO |
| Michael G. Maselli | 59 | VP of Acquisitions |
| Andrea J. Kellett | 62 | CFO |
| Hillel Weinberger | 65 | Director |
| Marc Mazur | 59 | Director |
| Paul S. Levy | 71 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Cantor Fitzgerald | BR | 25,000,000 | units |
| 25,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.